Aushon BioSystems, Inc, the leading provider of advanced microarray instrumentation and laboratory services for biomarker analysis, has appointed Joseph Blanchard as the company’s Chief Operating Officer. Mr. Blanchard brings more than 20 years of leadership experience in the global life sciences market to his new role, including senior level positions in corporate development, operations management, business development and sales. Mr. Blanchard joins Aushon from Decision Biomarkers, where he served as the Senior Vice President of Business Development and Strategy.

“Strengthening our operations team is critical to our continued growth,” said Peter Honkanen, CEO of Aushon. “Joe’s proven leadership ability, successful track record in introducing technology intensive products to the market and demonstrated skill in growing other thriving companies will ensure that our organization achieves continued success.”

“This is an extremely exciting time to be joining Aushon,” said Mr. Blanchard. “The need for improved microarray technologies used in the multibillion dollar biomarker market is enormous. By leveraging the breadth of our technology and expertise, we have a tremendous opportunity to capitalize on this growing demand.”

About Aushon BioSystems

Aushon BioSystems provides advanced microarray products, instruments and services for life science research, drug discovery/development and diagnostics. The Company’s proprietary 2470 Arrayer — now used in leading research centers around the world — enables researchers in the life science and pharmaceutical industries to create high quality arrays ranging from DNA to cell lysates. Aushon BioSystems is a privately held company based in Billerica, MA. For more information about Aushon BioSystems, please visit the company’s website at https://www.aushon.com.